IRRAS Logo

IRRAS

Develops innovative fluid exchange & ICP monitoring systems for neurocritical care patients.

IRRAS | ST

Overview

Corporate Details

ISIN(s):
SE0008321202
LEI:
549300EKKVQN2J25MJ59
Country:
Sweden
Address:
VASAGATAN 16, 111 20 Stockholm
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

IRRAS is a global, commercial-stage medical device company that develops and commercializes innovative solutions for neurocritical care. The company focuses on addressing conditions such as traumatic brain injuries and hemorrhagic strokes. Its flagship product, the IRRAflow system, is an advanced fluid exchange and intracranial pressure monitoring technology that combines controlled irrigation with drainage. IRRAS aims to transform patient outcomes, improve the standard of care for critically ill patients, and reduce the overall cost of treatment through its portfolio of neurocritical care products.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-10-20 17:46
Delisting Announcement
IRRAS’s application for delisting has been approved and the Board of Directors …
English 126.4 KB
2023-10-20 17:46
Delisting Announcement
IRRAS ansökan om avnotering har godkänts och styrelsen har fattat beslut om att…
Swedish 125.5 KB
2023-10-20 00:06
Pre-Annual General Meeting Information
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF IRRAS AB
English 172.4 KB
2023-10-20 00:06
Pre-Annual General Meeting Information
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IRRAS AB
Swedish 186.8 KB
2023-10-16 18:30
Prospectus
IRRAS publishes prospectus
English 1.7 MB
2023-10-16 18:30
Prospectus
IRRAS offentliggör prospekt
Swedish 1.7 MB
2023-10-16 13:14
Major Shareholding Notification
English 35.3 KB
2023-10-15 21:45
Capital/Financing Update
IRRAS has extended maturity date for its SEK 20 million short-term loan
English 71.9 KB
2023-10-15 21:45
Capital/Financing Update
IRRAS har senarelagt förfallodagen för dess kortfristiga lån om SEK 20 miljoner
Swedish 86.6 KB
2023-10-13 18:00
Share Issue/Capital Change
Kommuniké från extra bolagsstämma i IRRAS AB (publ) den 13 oktober 2023
Swedish 104.6 KB
2023-10-13 18:00
Share Issue/Capital Change
Bulletin from the Extraordinary General Meeting in IRRAS AB (publ) on 13 Octobe…
English 138.2 KB
2023-09-18 20:31
Share Issue/Capital Change
Statement by the Board of Directors of IRRAS AB
English 201.2 KB
2023-09-18 20:30
Pre-Annual General Meeting Information
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IRRAS AB (PUBL)
Swedish 187.2 KB
2023-09-15 08:00
Capital/Financing Update
IRRAS säkrar utökad bryggfinansiering
Swedish 186.1 KB
2023-09-15 08:00
Capital/Financing Update
IRRAS Secures Extended Short-Term Loan Agreement
English 157.8 KB

Automate Your Workflow. Get a real-time feed of all IRRAS filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IRRAS

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IRRAS via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-10-13 Marios Fotiadis Other Other 338,264,840 60,887,671.20 SEK
2023-09-18 Marios Fotiadis Other Buy 9,185,346 1,653,362.28 SEK
2023-09-04 MARIOS FOTIADIS Other Sell 1,277,700 229,986.00 SEK
2021-06-11 Bacara Holdings Limited Other Other 3,500,000 17,500,000.00 SEK
2021-06-11 Kleanthis Xanthopoulos Other Other 200,000 1,000,000.00 SEK
2021-05-04 Sabina Berlin Other Buy 8,532 49,997.52 SEK
2020-09-24 Carl Martin Other Buy 14,859 99,950.55 SEK
2020-09-22 Carl Martin Other Buy 5,141 33,365.09 SEK
2020-04-09 Anders Paul Wiklund Other Other 17,134 99,377.20 SEK
2020-04-09 Sabina Berlin Other Other 7,280 42,224.00 SEK

Peer Companies

Bone Biologics Corp Logo
Developing a protein-based bone graft for targeted bone regeneration in spinal fusion.
United States of America
BBLG
Bonesupport Holding Logo
Develops & markets injectable bioceramic bone grafts that remodel into bone to heal fractures.
Sweden
BONEX
Bonyf N.V. Logo
Develops patented oral, dental, and dermatological care products for consumers and professionals.
Belgium
MLBON
BOSTON SCIENTIFIC CORP Logo
Develops innovative, less-invasive medical devices for various interventional specialties.
United States of America
BSX
Boule Diagnostics Logo
Global provider of complete hematology systems for human and veterinary diagnostics.
Sweden
BOUL
BrainCool AB Logo
Develops medical cooling systems to protect the brain after cardiac arrest, stroke, or injury.
Sweden
BRAIN
CARLSMED, INC. Logo
AI-driven planning and patient-specific 3D-printed implants for spinal fusion surgery.
United States of America
CARL
Carl Zeiss Meditec AG Logo
Develops medical tech for ophthalmology & microsurgery, from diagnostics to surgical systems.
Germany
AFX
CARMAT Logo
Develops an implantable artificial heart as a bridge-to-transplant for heart failure patients.
France
ALCAR
CASTLE BIOSCIENCES INC Logo
Provides genomic tests for dermatologic cancers to guide personalized treatment decisions.
United States of America
CSTL

Talk to a Data Expert

Have a question? We'll get back to you promptly.